Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety

Launched by DR. NAZANIN ALAVI · Mar 3, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring an online therapy program designed to help women who are experiencing anxiety during perimenopause, which is the transitional phase leading up to menopause. The trial aims to find out if this internet-delivered therapy, which includes techniques from Cognitive Behavioural Therapy (CBT) and Acceptance Commitment Therapy (ACT), is effective and easy for women to use to manage their anxiety.

To participate, women must be in the perimenopausal stage and have a diagnosis of Generalized Anxiety Disorder (GAD). They should also be able to read and speak English and have reliable internet access. Throughout the study, participants will engage in weekly online therapy sessions tailored to their needs and receive feedback from trained professionals. They will complete surveys at different points during the trial to track their anxiety levels. This is a great opportunity for women looking for support during this phase of life, and it may lead to new ways to help manage anxiety.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • In perimenopausal staging (as defined by the STRAW +10 criteria)
• • Assigned female at birth
• • Diagnosis of GAD according to DSM-5 by attending psychiatrist on research team
• • Competence to consent to participate
• • Ability to speak and read English
• • Consistent and reliable access to the internet
• Exclusion Criteria:
• • Undergone CBT or hormone therapy within the last 6 months will be excluded
• • Active psychosis
• • Acute mania
• • Severe alcohol or substance use disorder
• • Active suicidal or homicidal ideation